Oramed Pharmaceuticals Fundamental Relationships

ORMP -- Israel Stock  

null 1,255  58.00  4.42%

The Drivers Module shows relationships between Oramed Pharmaceuticals's most relevant fundamental drivers and provides multiple suggestions of what could possibly affect the performance of Oramed Pharmaceuticals over time as well as its relative position and ranking within its peers. Additionally take a look at Your Equity Center.

Oramed Pharmaceuticals Revenue vs. Return On Asset Fundamental Analysis

Oramed Pharmaceuticals is regarded fourth in return on asset category among related companies. It is regarded fourth in revenue category among related companies .
Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Oramed Pharmaceuticals 
Return on Asset 
 = 
Net Income 
Total Assets 
X
100 
=
(24.81)%
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of business and is important item when evaluating financial statements of a company. Revenues from a firm's main business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which given company operates.
Oramed Pharmaceuticals 
Revenue 
 = 
Money Received 
Discounts and Returns 
=
2.57M
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can includes product or services discounts, promotions, as well as early payments on invoices or services rendered in advance.

Oramed Pharmaceuticals Fundamental Comparison

Search macroaxis.com